Corbus Pharmaceuticals Holdings (CRBP) Cash from Operations Growth (5y) (2018 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Cash from Operations Growth (5y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,380.63 Bn | 66,380.34 Bn | - |
| 2 | Nanobiotix | 1,910.39 Bn | 1,910.33 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 470.95 Bn | 466.16 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - |
| 8 | Argenx Se | 55.76 Bn | 50.58 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn |
| 10 | Corbus Pharmaceuticals Holdings | 112.00 Mn | 84.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 10.62% |
| Jun 30, 2025 | 9.01% |
| Mar 31, 2025 | 9.86% |
| Dec 31, 2024 | 13.47% |
| Sep 30, 2024 | 3.99% |
| Jun 30, 2024 | 11.41% |
| Mar 31, 2024 | -22.62% |
| Dec 31, 2023 | 15.64% |
| Sep 30, 2023 | 4.10% |
| Jun 30, 2023 | -7.02% |
| Mar 31, 2023 | -56.71% |
| Dec 31, 2022 | 3.94% |
| Sep 30, 2022 | -2.73% |
| Jun 30, 2022 | -16.43% |
| Mar 31, 2022 | -9.85% |
| Dec 31, 2021 | -12.11% |
| Sep 30, 2021 | 17.93% |
| Jun 30, 2021 | -47.31% |
| Mar 31, 2021 | -54.04% |
| Dec 31, 2020 | -83.29% |